WVE - Why Is Genetic Medicines-Focused Wave Life Sciences Stock Trading Lower Today? | Benzinga
Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately $100 million gross proceeds.
In addition, Wave Life Sciences has granted the underwriters a 30-day option to purchase up to an additional 3 million shares. The offering is expected to close on or about December 11.
Thursday, Wave Life Sciences initiated dosing in ...